Colgate-Palmolive reported accelerated top and bottom-line growth in Q4 2025, driven by strength in oral care and pet nutrition, despite sluggish category growth. The company is building on its 2025 strategy with a new 2030 plan focused on innovation, demand generation, and data analytics to drive consistent earnings growth.
Full year net sales and organic sales increased 1.4%, driven by strength in oral care and pet nutrition.
positiveBase Business EPS increased 3% for the full year and 4% in Q4.
positiveNet sales increased 5.8% in Q4, with organic sales up 2.2%.
positiveRecord net cash provided by operations of $4,198 million for the full year.
positiveGAAP EPS declined 25% for the full year to $2.63 and 106% in Q4 to $(0.05), driven by a $919 million goodwill and intangible assets impairment charge related to the skin health business.
negativeFull year gross profit margin decreased 40 bps to 60.1%, and Q4 gross profit margin decreased 10 bps to 60.2%.
attentionOperating profit margin declined significantly to 16.2% for the full year (down 500 bps) and 1.8% in Q4 (down 1970 bps) due to impairment charges.
negativeAsia Pacific sales decreased 0.3% as reported and 11% in operating profit in Q4.
attentionInventories increased to $2,032 million from $1,987 million YoY.
attentionMargin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
| Segment | Current | Prior Yr | YoY | % Total |
|---|---|---|---|---|
Oral, Personal and Home Care | N/A | — | — | — |
Pet Nutrition | N/A | — | — | — |
| Total Revenue | $0.00M | — | — | 100.0% |
Segment performance shows business unit health and growth drivers.
Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.
We are pleased to have exited 2025 with accelerated growth momentum on both the top and bottom lines, even in the face of sluggish category growth in many markets.
Our 2025 performance highlights the resilience of our business model and the strength of our brands.
Our new 2030 strategy builds on that success. We have laid out a clear path to accelerate our growth going forward with a focus on leveraging the global reach and penetration of our brands, building the incremental benefit of superior, science-based innovation, harnessing the power of best-in-class omni-channel demand generation, leading in capabilities like data, analytics and AI and evolving our high-impact, inclusive culture.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.